Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccine value profile for leishmaniasis
Paul M. Kaye, Greg Matlashewski, Sakshi Mohan, et al.
Vaccine (2023) Vol. 41, pp. S153-S175
Open Access | Times Cited: 23

Showing 23 citing articles:

Evaluation of the immunogenicity of a DNA vaccine for Leishmania major based on the Leishmania-activated C kinase antigen using calcium phosphate and chitosan adjuvants
Abdolaziz Gharaei, Mahmoud Rahdar, Oghlniaz Jorjani, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene (2025)
Closed Access | Times Cited: 1
A systematic review on the anti-microbial activities and structure-activity relationship (SAR) of quinoxaline derivatives
Sri Mounika Bellapukonda, Rani Bandela, Anuradha Singampalli, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117472-117472
Closed Access | Times Cited: 1
Leishmania vaccine development: A comprehensive review
Isha Saini, Jyoti Joshi, Sukhbir Kaur
Cellular Immunology (2024) Vol. 399-400, pp. 104826-104826
Closed Access | Times Cited: 8
The role of vaccines in reducing antimicrobial resistance: A review of potential impact of vaccines on AMR and insights across 16 vaccines and pathogens
Mateusz Hasso-Agopsowicz, Erin Sparrow, Alexandra Meagan Cameron, et al.
Vaccine (2024) Vol. 42, Iss. 19, pp. S1-S8
Open Access | Times Cited: 8
Memory T cells: promising biomarkers for evaluating protection and vaccine efficacy against leishmaniasis
Mahmoud Nateghi Rostami, Yahya Sohrabi
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Safety and reactogenicity of a controlled human infection model of sand fly-transmitted cutaneous leishmaniasis
Vivak Parkash, Helen Ashwin, Shoumit Dey, et al.
Nature Medicine (2024) Vol. 30, Iss. 11, pp. 3150-3162
Open Access | Times Cited: 7
Evaluation of the Anti-Leishmanial Activity of the Hydroalcoholic Extract of Green Algae (Spirogyra): Investigation of Weight Indicators (Lesion Size and Organ Weights) in BALB/c Mice
R. Zarezadeh Mehrizi, Ali Fattahi Bafghi, Vahid Nasiri, et al.
Acta Parasitologica (2025) Vol. 70, Iss. 1
Closed Access
Leishmaniasis in Syria – A Call for Action of the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Study Groups for Infections in Travellers and Migrants (ESGITM) and for Clinical Parasitology (ESGCP)
Aula Abbara, Marta Sanz, Ayla AlKharrat, et al.
Travel Medicine and Infectious Disease (2025), pp. 102849-102849
Open Access
Evaluation of Immunopharmacological efficacy of live Leishmania donovani overexpressing Ld_ζ1domain for protection against experimental human visceral Leishmaniasis.
Ruby Bansal, Sadat Shafi, Prachi Garg, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114295-114295
Open Access
CRISPR/Cas9-mediated deletion of a kinetoplast-associated gene attenuates virulence in Leishmania major parasites
Fatemeh Darzi, Ali Khamesipour, Minoo Tasbihi, et al.
Medical Microbiology and Immunology (2025) Vol. 214, Iss. 1
Closed Access
Comprehensive insights into leishmaniasis: From etiopathogenesis to a novel therapeutic approach
Zarbakht Ansari Pirsaraei, Ajeet Kumar Chaurasia, Neha Bhutiani, et al.
Microbial Pathogenesis (2025), pp. 107535-107535
Closed Access
From classical approaches to new developments in genetic engineering of live attenuated vaccine against cutaneous leishmaniasis: potential and immunization
Zahra Rooholamini, Hassan Dianat‐Moghadam, Mahsa Esmaeilifallah, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 2
Nicotinamide mitigates visceral leishmaniasis by regulating inflammatory response and enhancing lipid metabolism
Qi Zhou, Zhiwan Zheng, Shuangshuang Yin, et al.
Parasites & Vectors (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
A review of non-invasive samples and tools in kala-azar diagnosis and test of cure
Saravanan Vijayakumar, Priyanka Kriti Narayan, Shobha Kumari, et al.
Experimental Parasitology (2024) Vol. 259, pp. 108713-108713
Closed Access | Times Cited: 1
CRISPR/Cas9-mediated deletion of a kinetoplast-associated gene attenuates virulence inLeishmania majorparasites
Fatemeh Darzi, Ali Khamesipour, Maryam Bahrami, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Safety, effectiveness, and skin immune response in a controlled human infection model of sand fly transmitted cutaneous leishmaniasis
Vivak Parkash, Helen Ashwin, Shoumit Dey, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
The Full Value of Vaccine Assessments Concept—Current Opportunities and Recommendations
Richard G. White, Nicolas A. Menzies, Allison Portnoy, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 435-435
Open Access
Prioritizing Endemic Pathogens for Vaccine Research and Development by Capturing Regional and Country Stakeholder Values
Mateusz Hasso-Agopsowicz, Angela Hwang, Maria-Graciela Hollm-Delgado, et al.
(2024)
Closed Access
Development of Amphotericin B Decorated Gold Nanoparticles as a Promising Antileishmanial Nanoconjugate
Kikku Sharma, Juhi Shah, Sanjay Singh, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 9, pp. 6239-6248
Closed Access
Differential Immune Responses of Th1 Stimulatory Chimeric Antigens of Leishmania donovani in BALB/c Mice
Niharika Gupta, Alok Kumar Yadav, Pramod Kumar Verma, et al.
ACS Infectious Diseases (2024)
Closed Access
Investigating disease awareness of cutaneous leishmaniasis in rural Sri Lanka to inform public health services: a cross-sectional study
Sonali Gunasekara, Thilini Chanchala Agampodi, Manjula Weerasinghe, et al.
BMJ Open (2024) Vol. 14, Iss. 11, pp. e088714-e088714
Open Access
A Novel Colorimetric Assay for Early Differentiation of Mucocutaneous and Cutaneous Leishmaniasis Via Species-Specific Identification
Nancy Villegas Villaoa, Mavys Tabraue-Chávez, Cristina Megino-Luque, et al.
(2024)
Closed Access
CpG-adjuvanted virus-like particle vaccine induces protective immunity against Leishmania donovani infection
Keon-Woong Yoon, Ki‐Back Chu, Gi-Deok Eom, et al.
The Journal of Infectious Diseases (2024)
Closed Access
Page 1

Scroll to top